key: cord-1001054-da10t49m
authors: Fernández-Pittol, Mariana; Hurtado, Juan Carlos; Moreno-García, Estela; Rubio, Elisa; Navarro, Mireia; Valiente, Marta; Peiró, Aida; Capón, Alicia; Seijas, Nuria; Martínez, Miguel J.; Casals-Pascual, Climent; Vila, Jordi
title: Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19
date: 2020-06-26
journal: bioRxiv
DOI: 10.1101/2020.06.25.172734
sha: 84cdfc0758fa9f3c1c8c44faf0b58a7965a92704
doc_id: 1001054
cord_uid: da10t49m

The objective of this study was to assess the performance of direct real time RT-PCR detection of SARS-CoV-2 in heated saliva samples, avoiding the RNA isolation step. Oropharyngeal and nasopharyngeal swabs together with saliva samples were obtained from 51 patients clinically diagnosed as potentially having COVID-19. Two different methods were compared: 1. RNA was extracted from 500 μl of sample using a MagNA Pure Compact Instrument with an elution volume of 50μl and 2. 700µL of saliva were heat-inactivated at 96°C for 15 minutes, and directly subjected to RT-PCR. One step real time RT-PCR was performed using 5 μl of extracted RNA or directly from 5 μl of heated sample. RT-PCR was performed targeting the SARS-CoV-2 envelope (E) gene region. Diagnostic performance was assessed using the results of the RT-PCR from nasopharyngeal and oropharyngeal swabs as the gold standard. The overall sensitivity, specificity, positive and negative predictive values were 81.08%, 92.86%, 96.77% and 65.00%, respectively when RNA extraction was included in the protocol with saliva, whereas sensitivity, specificity, positive and negative predictive values were 83.78%, 92.86%, 68.42% and 96.88%, respectively, for the heat-inactivation protocol. However, when the analysis was performed exclusively on saliva samples with a limited time from the onset of symptoms (<9 days, N=28), these values were 90%, 87.5%, 44% and 98.75% for the heat-inactivation protocol. The study showed that RT-PCR can be performed using saliva in an RNA extraction free protocol, showing good sensitivity and specificity.

The objective of this study was to assess the performance of direct real time RT-PCR detection 25 of SARS-CoV-2 in heated saliva samples, avoiding the RNA isolation step. Oropharyngeal and 26 nasopharyngeal swabs together with saliva samples were obtained from 51 patients clinically 27 diagnosed as potentially having COVID-19. Two different methods were compared: 1. RNA was 28 extracted from 500 μl of sample using a MagNA Pure Compact Instrument with an elution 29 volume of 50μl and 2. 700µL of saliva were heat-inactivated at 96 o C for 15 minutes, and directly 30 subjected to RT-PCR. One step real time RT-PCR was performed using 5 μl of extracted RNA or 31 directly from 5 μl of heated sample. RT-PCR was performed targeting the SARS-CoV-2 envelope 32 (E) gene region. Diagnostic performance was assessed using the results of the RT-PCR from 33 nasopharyngeal and oropharyngeal swabs as the gold standard. The overall sensitivity, 34 specificity, positive and negative predictive values were 81.08%, 92.86%, 96.77% and 65.00%, 35 respectively when RNA extraction was included in the protocol with saliva, whereas sensitivity, 36 specificity, positive and negative predictive values were 83.78%, 92.86%, 68.42% and 96.88%, 37 respectively, for the heat-inactivation protocol. However, when the analysis was performed 38 exclusively on saliva samples with a limited time from the onset of symptoms (<9 days, N=28), 39 these values were 90%, 87.5%, 44% and 98.75% for the heat-inactivation protocol. The study 40

showed that RT-PCR can be performed using saliva in an RNA extraction free protocol, showing 41 good sensitivity and specificity.

COVID-19 is a very devastating pandemic infection caused by SARS-CoV-2, which 46 originated in China and has currently spread all over the world 1 . Rapid diagnosis of COVID-19 is 47 essential for the management of patients mainly in the emergency department 2 . Although 48 some assays based on antigen-antibody reaction have been commercialized to detect either 49 antigens or antibodies (IgA, IgM or IgG), the most sensitive tool to detect SARS-CoV-2 continues 50 to be reverse-transcription real time polymerase chain reaction (RT-PCR) which specifically 51 amplifies different genes encoded in the viral RNA from nasopharyngeal and/oropharyngeal 52

Shortages in swabs for collecting nasopharyngeal and oropharyngeal samples as well as 54 insufficient RNA extraction kits can lead to a critical situation during a pandemic in which a 55 huge number of samples must be processed. Therefore, the main objective of this study was to 56 evaluate the use of saliva as an alternative and easier-to-collect clinical sample to detect 57 COVID-19. The diagnostic performance of nasopharyngeal and oropharyngeal swabs was 58 compared to the performance of direct heated saliva to RNA extracted samples. days, N=28), these values were 90%, 87.5%, 44% and 98.75% for the heat-inactivation protocol 103 (Table) . extraction. In addition, the cost is also decreased. Moreover, the combination of a test with a 121 high negative predictive value, and the simplified logistics of sample collection (patients provide 122 the saliva samples with no need for personal protective equipment) is especially helpful to rule 123 out infection during times of low incidence and also in low-resource settings. Larger studies are 124 needed to prospectively validate these findings, and standardized saliva sample collection 125 protocols are also necessary prior to implementation in the clinical setting. 126 127

COVID-19 infection: the China and Italy perspectives

Laboratory diagnosis of emerging human coronavirus infections -131 the state of the art

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Consistent detection of 2019 novel coronavirus in 139 saliva

Temporal profiles of viral load in posterior oropharyngeal 142 saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational 143 cohort study

Saliva sample as a non-invasive 145 specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study

online ahead of print

Saliva is more sensitive for SARS-CoV-2 150 detection in COVID-19 patients than nasopharyngeal swabs